Accelerated BEP: a phase I trial of dose-dense BEP for intermediate and poor prognosis metastatic germ cell tumour

BACKGROUND: We used bleomycin, etoposide, cisplatin (BEP), the most effective regimen in the treatment of germ cell tumours (GCTs) and increased dose-density by using pegfilgrastim to shorten cycle length. Our aim was to assess safety and tolerability. METHODS: Sixteen male patients with intermediat...

Descripción completa

Detalles Bibliográficos
Autores principales: Rimmer, Y, Chester, J, Joffe, J, Stark, D, Shamash, J, Powles, T, White, J, Wason, J, Parashar, D, Armstrong, G, Mazhar, D, Williams, M V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171015/
https://www.ncbi.nlm.nih.gov/pubmed/21847130
http://dx.doi.org/10.1038/bjc.2011.309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171015/
https://www.ncbi.nlm.nih.gov/pubmed/21847130
http://dx.doi.org/10.1038/bjc.2011.309

Ejemplares similares